In this presentation, Tim Lane, Director of Business Development, and Eugene Kim, Director of Supply Chain of will provide an update on Bora’s latest investments and expanded fill/finish capabilities and capacity for small molecules, biologics and other sterile injectable products.

With extensive experience in tech transfer and scale up to commercialization, Bora is well equipped to support your unique cGMP program needs.